SL-1002

· Saol Therapeutics Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SL-1002, covering 2023-08-29 to 2023-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity [Phase 2]